Soumon Rudra
YOU?
Author Swipe
View article: Virtual Medical Student Education in a Post-Pandemic World: Lessons from a Multi-Institutional Virtual Radiation Oncology Clerkship
Virtual Medical Student Education in a Post-Pandemic World: Lessons from a Multi-Institutional Virtual Radiation Oncology Clerkship Open
View article: Reirradiation clinical practice in gastrointestinal abdominal malignancies: an international reirradiation collaborative group (ReCOG) systematic review
Reirradiation clinical practice in gastrointestinal abdominal malignancies: an international reirradiation collaborative group (ReCOG) systematic review Open
Reirradiation in abdominal malignancies appears to be able to achieve meaningful local control and survival in select patients, though heterogeneity in planning, dosing, and toxicity reporting remains a major challenge for establishing bes…
View article: Supplementary Table S1 from Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer
Supplementary Table S1 from Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer Open
Supplementary Table 1. Representativeness of Study Participants
View article: Data from Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer
Data from Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer Open
Purpose:Tolinapant is an inhibitor of apoptosis protein antagonist that enhances apoptotic pathways. In preclinical studies, tolinapant + radiotherapy (RT) enhances antitumor immunity. We conducted an open-label, single-arm trial to evalua…
View article: Treatment of recurrent oral carcinoma cuniculatum with immune checkpoint blockade: A case report and literature review
Treatment of recurrent oral carcinoma cuniculatum with immune checkpoint blockade: A case report and literature review Open
Though it has a low propensity for metastasis, oral CC is a locally aggressive variant of squamous cell carcinoma, and recurrences are difficult to treat. Although reports of systemic therapy for CC are limited, this case suggests that imm…
View article: Assessment of automated non-coplanar stereotactic radiosurgery planning in single isocenteric linac-based treatment for brain metastases with respect to planner’s experience
Assessment of automated non-coplanar stereotactic radiosurgery planning in single isocenteric linac-based treatment for brain metastases with respect to planner’s experience Open
View article: Supplementary Table S2 from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis
Supplementary Table S2 from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis Open
Supplementary Table S2. OS versus lymphoid markers.
View article: Supplementary Table S3 from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis
Supplementary Table S3 from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis Open
Supplementary Table S3. OS versus myeloid markers.
View article: Supplementary Table S1 from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis
Supplementary Table S1 from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis Open
Supplementary Table S1. Study representativeness.
View article: Data from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis
Data from Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis Open
Purpose:Anti-programmed cell death protein 1 (PD-1) therapy is a standard of care in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC). Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR…
View article: Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis Open
Purpose: Anti-programmed cell death protein 1 (PD-1) therapy is a standard of care in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC). Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGF…
View article: DOSE ESCALATION TRIAL OF PROTON FLASH-RT TO SPINAL CORD IN A LARGE ANIMAL MODEL: QUANTIFICATION OF THE FLASH EFFECT
DOSE ESCALATION TRIAL OF PROTON FLASH-RT TO SPINAL CORD IN A LARGE ANIMAL MODEL: QUANTIFICATION OF THE FLASH EFFECT Open
View article: Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma Open
Importance Intensity-modulated radiation therapy (IMRT) reirradiation of nonmetastatic recurrent or second primary head and neck squamous cell carcinoma (HNSCC) results in poor progression-free survival (PFS) and overall survival (OS). Obj…
View article: Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma Open
Importance Patients with locally advanced non–human papillomavirus (HPV) head and neck cancer (HNC) carry an unfavorable prognosis. Chemoradiotherapy (CRT) with cisplatin or anti–epidermal growth factor receptor (EGFR) antibody improves ov…
View article: Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric features
Prediction of plan adaptation in head and neck cancer proton therapy using clinical, radiographic, and dosimetric features Open
There are several dosimetric and clinical features that correlate to re-plans, and NNs trained with these features can be used to predict HN re-plans, which can be used to reduce re-plan rate by improving plan quality.
View article: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial Open
View article: Ninety‐day mortality following transoral robotic surgery or radiation at Commission on Cancer‐accredited facilities
Ninety‐day mortality following transoral robotic surgery or radiation at Commission on Cancer‐accredited facilities Open
Background Postoperative mortality for oropharynx squamous cell carcinoma (OPSCC) with transoral robotic surgery (TORS) varies from 0.2% to 6.5% on trials; the real‐world rate is unknown. Methods NCDB study from 2010 to 2017 for patients w…
View article: Contents
Contents Open
View article: Multi-organ auto-delineation in head-and-neck MRI for radiation therapy using regional convolutional neural network
Multi-organ auto-delineation in head-and-neck MRI for radiation therapy using regional convolutional neural network Open
Magnetic resonance imaging (MRI) allows accurate and reliable organ delineation for many disease sites in radiation therapy because MRI is able to offer superb soft-tissue contrast. Manual organ-at-risk delineation is labor-intensive and t…
View article: Reduced Intubation Rates Following Whole-Lung Low-Dose Radiation Therapy (LD-RT) in Patients With COVID-19-Related Pneumonia
Reduced Intubation Rates Following Whole-Lung Low-Dose Radiation Therapy (LD-RT) in Patients With COVID-19-Related Pneumonia Open
View article: CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) ― Toxicity and Quality of Life (QoL) Results
CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) ― Toxicity and Quality of Life (QoL) Results Open
View article: Rapid Comparative Planning to Predict Oropharyngeal Toxicity Reduction for Proton Therapy vs. VMAT
Rapid Comparative Planning to Predict Oropharyngeal Toxicity Reduction for Proton Therapy vs. VMAT Open
View article: Cone Beam CT-Based Online Evaluation in Two Minutes Using a Commercial Treatment Planning Software for Proton Therapy
Cone Beam CT-Based Online Evaluation in Two Minutes Using a Commercial Treatment Planning Software for Proton Therapy Open
View article: Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with COVID-19-related pneumonia receiving dexamethasone and/or remdesevir
Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with COVID-19-related pneumonia receiving dexamethasone and/or remdesevir Open
View article: Evaluation of interim MRI changes during limited-field radiation therapy for glioblastoma and implications for treatment planning
Evaluation of interim MRI changes during limited-field radiation therapy for glioblastoma and implications for treatment planning Open
View article: Response to Whole-Lung Low-Dose Radiation Therapy (LD-RT) Predicts Freedom from Intubation in Patients Receiving Dexamethasone and/or Remdesevir for COVID-19-Related Acute Respiratory Distress Syndrome (ARDS)
Response to Whole-Lung Low-Dose Radiation Therapy (LD-RT) Predicts Freedom from Intubation in Patients Receiving Dexamethasone and/or Remdesevir for COVID-19-Related Acute Respiratory Distress Syndrome (ARDS) Open
Background Phase I/II clinical trials have explored whole-lung low-dose radiotherapy (LD-RT) as a potential treatment for patients with COVID-19-related acute respiratory distress syndrome (ARDS). Initial findings require reproduction. Con…
View article: The Role of MRI-Guided Radiation Therapy for Palliation of Mobile Abdominal Cancers: A Report of Two Cases
The Role of MRI-Guided Radiation Therapy for Palliation of Mobile Abdominal Cancers: A Report of Two Cases Open
View article: Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma Open
Background Optimal management for recurrent IDH-mutant glioma after radiation therapy (RT) is not well-defined. This study assesses practice patterns for managing recurrent IDH-mutant astrocytoma (Astro) and 1p/19q codeleted oligodendrogli…
View article: Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy
Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy Open
View article: Salvage Treatment for Recurrent IDH-mutant Diffuse Gliomas after Radiation Therapy
Salvage Treatment for Recurrent IDH-mutant Diffuse Gliomas after Radiation Therapy Open